AMR incentives could be next big EU opportunity, pharma boss says

Europe could become the first region worldwide to incentivise the fight anti-microbial resistance (AMR), Nathalie Moll, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), told EURACTIV in an interview.

Following the EU Council conclusions of June 2017, the European Commission adopted the EU One Health Action Plan against AMR. In this plan, the EU executive said there is a need to support research into the development of new economic models.